The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine
Ebtesam I Ahmad, Heba H Gawish, Nashwa MA Al Azizi, Ashraf M ElhefniClinical Pathology Department, Hematology and Oncology Unit of Internal Medicine Department, Faculty of Medicine, Zagazig University, Sharkia, EgyptBackground: Activating point mutation of the RAS gene has been generally accepted as...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-07-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/the-prognostic-impact-of-k-ras-mutations-in-adult-acute-myeloid-leukem-a7877 |
